Regression of Hamstring Flexibility and Performance in Children With Duchenne Muscular Dystrophy

September 27, 2019 updated by: Lütfiye AKKURT, PT, Hacettepe University
Investigator investigated that regression of hamstring flexibility and performance in children with Duchenne Muscular Dystrophy.

Study Overview

Detailed Description

Flexibility of hamstrings was evaluated by Popliteal Angle test. Performance was evaluated 6 Minute Walk Test (6 MWT). Regression of hamstring flexibility and performance was examined regression tests. Correlation was examined between popliteal angle test and parameter of North Star Ambulation Assessment.

Study Type

Observational

Enrollment (Actual)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sıhhiye
      • Ankara, Sıhhiye, Turkey
        • Hacettepe University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years to 14 years (Child)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

Male

Sampling Method

Probability Sample

Study Population

Sixty children will participated this study. Fourty-two children was assessed, and eighteen children will assess in a few months.

Description

Inclusion Criteria:

  • To be a Duchenne Muscular Dystrophy diagnosis,
  • Being in the ambulatory period and climbing four steps independently,
  • to be Level 1 and Level 2 according to Brooke Lower Functional Classification Test
  • To be able to cooperate
  • No any severe contracture in the lower limbs which may prevent assessments,

Exclusion Criteria:

  • Children who fail to meet these criteria study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Popliteal Angle Test
Time Frame: 5 minute
The Popliteal Angle Test was used to assess hamstring flexibility. Child asked to rise lower leg straight. Incomplete angle degree of full extension is popliteal angle.
5 minute

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
6 Minute Walk Test
Time Frame: 6 minute
6 Minute Walk Test was used to assess performance with children Duchenne MUscular Dystropy.
6 minute
North Star Ambulation Assessment
Time Frame: 20 minute
The North Star Ambulatory Assessment (NSAA) is used to assess mobility for in ambulatory children with DMD for 5 years. NSAA is consist of 17 items from stand to run.
20 minute

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ayşe Karaduman, Prof., Hacettepe University
  • Principal Investigator: İpek Gürbüz, Assoc.Prof., Hacettepe University
  • Principal Investigator: Güllü Aydın, Msc., Hacettepe University
  • Principal Investigator: Numan Bulut, Msc, Hacettepe University
  • Study Director: Oznur Yılmaz, Hacettepe University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 8, 2018

Primary Completion (Actual)

January 24, 2019

Study Completion (Actual)

January 24, 2019

Study Registration Dates

First Submitted

July 5, 2018

First Submitted That Met QC Criteria

July 5, 2018

First Posted (Actual)

July 18, 2018

Study Record Updates

Last Update Posted (Actual)

September 30, 2019

Last Update Submitted That Met QC Criteria

September 27, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Performance

3
Subscribe